newsfilter
← Latest News
GlobeNewswire·

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds

PRINCETON, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the entry into a definitive agreement